Barclays PLC grew its position in shares of Delek US Holdings, Inc. (NYSE:DK - Free Report) by 23.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,842,035 shares of the oil and gas company's stock after purchasing an additional 345,210 shares during the period. Barclays PLC owned approximately 2.92% of Delek US worth $34,078,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in DK. Geode Capital Management LLC boosted its position in shares of Delek US by 4.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,459,301 shares of the oil and gas company's stock worth $27,368,000 after acquiring an additional 63,502 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of Delek US by 6.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 766,807 shares of the oil and gas company's stock worth $14,186,000 after acquiring an additional 45,017 shares during the period. Easterly Investment Partners LLC boosted its stake in shares of Delek US by 2.9% in the fourth quarter. Easterly Investment Partners LLC now owns 765,249 shares of the oil and gas company's stock valued at $14,157,000 after buying an additional 21,210 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of Delek US by 76.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 482,169 shares of the oil and gas company's stock worth $9,041,000 after purchasing an additional 209,474 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of Delek US during the 4th quarter worth approximately $6,815,000. Institutional investors and hedge funds own 97.01% of the company's stock.
Insider Buying and Selling
In related news, CFO Mark Wayne Hobbs purchased 2,800 shares of the firm's stock in a transaction dated Tuesday, March 11th. The stock was purchased at an average price of $13.70 per share, with a total value of $38,360.00. Following the completion of the purchase, the chief financial officer now owns 49,138 shares of the company's stock, valued at approximately $673,190.60. The trade was a 6.04 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. In the last quarter, insiders bought 5,055 shares of company stock valued at $70,787. Company insiders own 1.80% of the company's stock.
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on DK shares. UBS Group decreased their target price on Delek US from $21.00 to $13.25 and set a "neutral" rating for the company in a report on Wednesday, April 9th. Piper Sandler dropped their target price on shares of Delek US from $18.00 to $17.00 and set a "neutral" rating on the stock in a report on Friday, March 7th. Scotiabank lowered their price objective on Delek US from $24.00 to $14.00 and set a "sector perform" rating for the company in a research note on Friday, April 11th. Morgan Stanley reduced their price target on shares of Delek US from $19.00 to $18.00 and set an "underweight" rating for the company in a research note on Friday, March 14th. Finally, Raymond James cut their price target on shares of Delek US from $24.00 to $23.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Five equities research analysts have rated the stock with a sell rating, six have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $17.48.
Get Our Latest Stock Analysis on DK
Delek US Trading Up 2.2 %
Shares of DK stock traded up $0.30 during mid-day trading on Thursday, hitting $13.43. The company's stock had a trading volume of 170,333 shares, compared to its average volume of 1,214,074. Delek US Holdings, Inc. has a 52 week low of $11.03 and a 52 week high of $29.69. The company's fifty day simple moving average is $14.77 and its 200-day simple moving average is $16.98. The company has a market cap of $839.24 million, a PE ratio of -2.75 and a beta of 1.04. The company has a debt-to-equity ratio of 3.18, a quick ratio of 0.67 and a current ratio of 1.04.
Delek US (NYSE:DK - Get Free Report) last posted its quarterly earnings results on Tuesday, February 25th. The oil and gas company reported ($2.54) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.53) by ($1.01). Delek US had a negative return on equity of 28.21% and a negative net margin of 2.27%. The company had revenue of $2.37 billion for the quarter, compared to the consensus estimate of $2.58 billion. During the same quarter in the previous year, the business earned ($1.46) earnings per share. Delek US's revenue was down 39.8% compared to the same quarter last year. As a group, equities research analysts expect that Delek US Holdings, Inc. will post -5.5 earnings per share for the current fiscal year.
Delek US Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Monday, March 10th. Shareholders of record on Monday, March 3rd were given a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 7.60%. The ex-dividend date was Monday, March 3rd. Delek US's payout ratio is -11.54%.
Delek US Profile
(
Free Report)
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
See Also

Before you consider Delek US, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.
While Delek US currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.